Condition

EBV Infection clinical trials and research

• 7Clinical trials
• 9Countries

Newest EBV Infection clinical trials

All recruiting trials (7)

• Virus-specific T cells for kids after stem cell transplant

  This trial tests whether giving virus-specific T cells can safely help children with CMV, EBV, or BKV infections after a stem cell transplant.

  Recruiting LucasBio · Seoul · NCT07685457

• Multi-Virus Specific T cells for antiviral-resistant CMV, BKV, or EBV after cancer therapy or stem cell transplant

  This trial tests LB-DTK-MV cells to see if they safely reduce CMV, BKV, or EBV in patients who have antiviral-resistant infections after cancer treatment or stem cell transplant.

  Recruiting Phase 1/2 LucasBio · Seoul · NCT07670468

• Valacyclovir versus valganciclovir to prevent CMV and EBV after kidney transplant

  This test checks whether valacyclovir works as well as valganciclovir to prevent CMV and EBV in people who recently had a kidney transplant.

  Recruiting National Taiwan University Hospital · Taipei · NCT07294547

• Using EBV-TCR-T cells to treat EBV-related conditions

  This study is testing a new treatment using special immune cells to see if it can help people with serious conditions related to the Epstein-Barr virus.

  Recruiting Phase 1 Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06135922

• T-cell therapy for viral infections after stem cell transplant

  This study is testing whether giving special T-cells that target specific viruses can help patients who have had a stem cell transplant and are struggling with tough viral infections.

  Recruiting at 33 sites Phase 3 University Hospital Freiburg · Brussels and 32 other locations · NCT04832607

• Evaluating 2LEBV® and 2LXFS® for fatigue in Epstein-Barr Virus patients

  This study is testing two new medications to see if they can help people aged 12 and older who have been feeling very tired due to Epstein-Barr Virus infections.

  Recruiting at 7 sites Phase 4 Labo'Life · Heule, Kortrijk and 7 other locations · NCT04308278

• Tracking outcomes of chronic EBV infection

  This study is tracking people with high levels of Epstein-Barr virus in their blood to see if it leads to blood cancers and to understand how the virus might affect the immune system.

  Recruiting Huazhong University of Science and Technology · Wuhan, Hubei · NCT03491605

Related topics

Quick answers

How many EBV Infection clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in China (2 trials), Belgium (2 trials), South Korea (2 trials), Taiwan (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 4: 1, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →